NewSelf Compounding Safety: Third-Party Testing, FDA Context & What to Verify

What Is a Compounded Medication?

Compounded medications are customized drug preparations made by licensed compounding pharmacies under a physician's prescription for an individual patient. They contain the same active pharmaceutical ingredient as brand-name drugs — in NewSelf's case, semaglutide (same active molecule as Ozempic and Wegovy) or tirzepatide (same active molecule as Mounjaro and Zepbound) — but are prepared outside the FDA's new drug approval process.

Compounding is legal and regulated at the state level by pharmacy boards. During active FDA drug shortage periods — which covered both semaglutide and tirzepatide through much of 2024–2025 — 503A compounding pharmacies are additionally authorized to prepare copies of shortage-listed drugs. This is the legal basis under which NewSelf's Semaglutide Plus⁺ and Tirzepatide Plus⁺ are prepared. As shortage designations change, compounding authorization may narrow — verify current status before enrolling.

NewSelf's Quality Testing Claims

NewSelf states that its partner 503A pharmacies conduct independent third-party laboratory testing of every medication batch. The three test categories:

These claims are made by NewSelf about its partner pharmacies. Always request the Certificate of Analysis (CoA) directly from your dispensing pharmacy when medication arrives to independently verify batch testing results.

The February 2026 FDA Warning Letter

An FDA warning letter does not automatically shut down a company or constitute a product recall. It requires a formal response and corrective action. The specific citations related to: characterizing compounded semaglutide in ways that misrepresented its regulatory status, and making claims about equivalence to brand-name products that the FDA found false or misleading. Verify NewSelf's current compliance status at the time you are considering enrollment.

What to Check When Your Medication Arrives

NewSelf's medications are temperature-sensitive. Semaglutide and tirzepatide degrade at sustained temperatures above 86°F (30°C). When your package arrives:

• Check cold packs immediately — they should still be cold or partially frozen
• If the package feels warm (above room temperature), document it with photos and contact NewSelf and your pharmacy within the 7-day reporting window
• Check the vial labels — confirm your name, medication name, concentration (mg/mL), lot number, and expiration date
• Verify you received the prescribed dosage strength, not a different concentration
• Request and review the Certificate of Analysis for your specific lot number
• Store properly: refrigerated between 36°F–46°F (2°C–8°C), protected from light

How Compounded GLP-1 Quality Compares to Brand-Name

Brand-name Wegovy and Zepbound are manufactured by Novo Nordisk and Eli Lilly respectively, under FDA Current Good Manufacturing Practice (cGMP) requirements — the highest regulatory standard for pharmaceutical manufacturing. The FDA reviews these products for safety, efficacy, and quality through a rigorous approval process before they reach patients.

Compounded medications from 503A pharmacies are not reviewed by the FDA before marketing. Quality assurance relies on the compounding pharmacy's own practices, state board oversight, and — in NewSelf's case — independent third-party testing. This is a real difference that patients should weigh, particularly those with health conditions that increase their sensitivity to medication quality variability. See our clinical sources for the full evidence base on GLP-1 efficacy.